REATA PHARMACEUTICALS
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases. It offers antioxidant inflammation-modulating drugs, as well as drugs that correct protein misfolding. The company also develops drugs for the treatment of renal/cardiovascular and autoimmune diseases. The company was formerly known as Reata Discovery, Inc. and changed its name to Reata Pharmaceuticals, Inc. in May 2005. The company was founded in 2002 and is based in Irving, Texas.
REATA PHARMACEUTICALS
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2002-01-01
Address:
Irving, Texas, United States
Country:
United States
Website Url:
http://www.reatapharma.com
Total Employee:
51+
Status:
Active
Contact:
972-865-2219
Total Funding:
1.37 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Content Delivery Network Google Universal Analytics Microsoft Exchange Online Office 365 Mail
Similar Organizations
Aerial BioPharma
Aerial BioPharma is a biopharmaceutical company developing biologics and small molecules for central nervous system issues.
Anavex
Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.
Apexigen
Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.
Aprecia Pharmaceuticals
Aprecia Pharmaceuticals develops precision drug delivery systems and products.
Ataxion
Ataxion is a discovery-stage biopharmaceutical company developing novel therapies for rare, debilitating, and underserved neurologic.
Atriva Therapeutics
Atriva is a biopharmaceutical company which aims to develop new antiviral therapies against different respiratory viral infections.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Cure Pharmaceutical
Cure Pharmaceutical is a specialty pharmaceutical and bioscience company, develops drug formulation and delivery technologies.
Emerald Health Pharmaceuticals
EHP is a biotech company developing biotechnology and cannabinoids science and technology to treat incurable diseases.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Euthymics Bioscience
Euthymics Bioscience, a neuroscience-focused biopharmaceutical company, develops medicines for central nervous system disorders.
Genelux
Genelux, a clinical-stage biopharmaceutical company, develops diagnostic and therapeutic solutions for cancer and inflammatory diseases.
KeChow Pharma
KeChow Pharma, Inc. is a biopharmaceutical company focused on novel drug discovery.
Lumos Pharma
Lumos Pharma is a biopharmaceutical company that develops a novel treatment for the rare disease Creatine Transporter Deficiency.
MAIA Pharmaceuticals
MAIA Pharmaceuticals identifies, develops, manufactures and markets innovative and niche generic products.
NewBridge Pharmaceuticals
Newbridge Pharmaceuticals is a pharmaceutical and medical device company engaged in developing oncology and supportive care products.
PeriphaGen
PeriphaGen is a biopharmaceutical company whose corporate objective is the development of first in class neuronal gene delivery products.
Regeneron
Regeneron Pharmaceuticals is a biotechnology company that invents life-transforming medicines for people with serious diseases.
RegeneRx
RegeneRx is a biopharmaceutical company that designs, researches, and develops novel peptides targeted at diseases with unmet medical needs.
Relypsa
Relypsa is a biopharmaceutical company developing drugs for treating cardiovascular and renal diseases.
Reneo Pharmaceuticals
Reneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases.
Samsara Therapeutics
Samsara Therapeutics is a biopharmaceutical company that aims to discover therapeutics to treat rare genetic and neurodegenerative disease.
Selecta Biosciences
Selecta Biosciences is a clinical-stage biotechnology company with an unrelenting commitment to overcoming immunogenicity.
SpringWorks Therapeutics
SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.
Synaptogenix
Synaptogenix is a clinical-stage biopharmaceutical company that develops novel therapies for neurodegenerative diseases.
TauRx Pharmaceuticals
TauRx Pharmaceuticals is a life sciences company developing drugs and diagnostics for neurodegenerative diseases.
Trevena
Trevena is a clinical stage biopharmaceutical company discovering and developing G-protein coupled receptors (GPCR) biased ligands.
Wren Therapeutics
Wren Therapeutics is a biopharmaceutical company based, focused on drug discovery and development for protein misfolding diseases.
Current Advisors List
Board_member
Board_member
Board_member
Current Employees Featured
Dawn C. Bir Chief Commercial Officer & Executive Vice President @ Reata Pharmaceuticals
Chief Commercial Officer & Executive Vice President
Colin Meyer Chief Medical Officer & Executive Vice President, Product Development @ Reata Pharmaceuticals
Chief Medical Officer & Executive Vice President, Product Development
Manmeet S. Soni Chief Financial Officer @ Reata Pharmaceuticals
Chief Financial Officer
2019-08-01
Michael Wortley Chief Legal Officer @ Reata Pharmaceuticals
Chief Legal Officer
Vinny Jindal Vice President Strategy @ Reata Pharmaceuticals
Vice President Strategy
2016-11-01
Manmeet S. Soni Chief Operating Officer @ Reata Pharmaceuticals
Chief Operating Officer
2020-06-01
Warren Huff CEO @ Reata Pharmaceuticals
CEO
2002-09-01
Founder
Stock Details
Investors List
Blackstone Life Sciences
Blackstone Life Sciences investment in Post-IPO Equity - Reata Pharmaceuticals
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Reata Pharmaceuticals
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Reata Pharmaceuticals
Novo Holdings
Novo Holdings investment in Venture Round - Reata Pharmaceuticals
CPMG
CPMG investment in Venture Round - Reata Pharmaceuticals
Novo Holdings
Novo Holdings investment in Series E - Reata Pharmaceuticals
CPMG
CPMG investment in Series E - Reata Pharmaceuticals
Startech Early Ventures
Startech Early Ventures investment in Series D - Reata Pharmaceuticals
Ojai Goliad
Ojai Goliad investment in Series D - Reata Pharmaceuticals
Cardinal Investment Co.
Cardinal Investment Co. investment in Series D - Reata Pharmaceuticals
Official Site Inspections
http://www.reatapharma.com Semrush global rank: 2.86 M Semrush visits lastest month: 5.66 K
- Host name: server-3-171-76-87.iad89.r.cloudfront.net
- IP address: 3.171.76.87
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Reata Pharmaceuticals"
Biogen to Acquire Reata Pharmaceuticals - Yahoo Finance
Jul 28, 2023 · Reata has made significant advancements developing therapeutics that regulate cellular metabolism and inflammation in serious neurologic diseases.See details»
Biogen to Acquire Reata Pharmaceuticals
Jul 28, 2023 · Reata’s FDA-approved SKYCLARYS ® (omaveloxolone) is the first and only approved treatment for Friedreich’s ataxia (FA) in the United States, with a commercial launch …See details»
Reata Pharmaceuticals, Inc. | LinkedIn
Reata Pharmaceuticals, Inc. | 22,841 followers on LinkedIn. Changing the landscape in life-threatening diseases | Reata Pharmaceuticals has been acquired by Biogen. Please follow …See details»
Reata Pharmaceuticals - Crunchbase Company Profile & Funding
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases. View contacts for Reata Pharmaceuticals to …See details»
Reata Pharmaceuticals - Overview, News & Similar companies
Reata Pharmaceuticals contact info: Phone number: (972) 865-2219 Website: www.reatapharma.com What does Reata Pharmaceuticals do? Founded in 2002, Reata …See details»
Biogen Completes Acquisition of Reata Pharmaceuticals - Yahoo …
CAMBRIDGE, Mass., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) – has completed the acquisition of Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a company …See details»
Reata Pharmaceuticals - Craft
Reata Pharmaceuticals has 5 employees across 3 locations and $2.22 m in annual revenue in FY 2022. See insights on Reata Pharmaceuticals including office locations, competitors, revenue, …See details»
Biogen Completes Acquisition of Reata Pharmaceuticals
CAMBRIDGE, Mass., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) – has completed the acquisition of Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a company …See details»
Reata Pharmaceuticals Stockholders Approve Merger Transaction …
Sep 21, 2023 · Reata is a global, biopharmaceutical company committed to developing and commercializing novel therapeutics for patients with serious or life-threatening diseases with …See details»
Reata Pharmaceuticals CEO and Key Executive Team | Craft.co
Reata Pharmaceuticals's key executives include Warren Huff and 17 others. Need Data? Craft can deliver 250+ data points of financial, operating, and human capital indicators on …See details»
Reata Pharmaceuticals - PitchBook
Developer of oral anti-inflammatory drugs intended for the treatment of serious and life-threatening diseases. The company focuses on identifying, developing, and commercializing …See details»
Reata Pharmaceuticals, Inc. To Report Fourth Quarter ... - Business …
Feb 18, 2022 · Reata is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular …See details»
Reata Pharmaceuticals, Inc. - Cruelty Free Investing
Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its products include …See details»
Reata Announces Promotion and New Hires For Key Leadership …
PLANO, Texas, July 07, 2020 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (RETA) (“Reata,” the “Company,” or “we”), a clinical-stage biopharmaceutical company, today …See details»
Reata Pharmaceuticals, Inc. | Insights
Oct 10, 2024 · The development road has been a rocky one for PTC Therapeutics, Inc. 's vatiquinone but the company has unveiled long-term data which will provide support for a …See details»
Reata Pharmaceuticals - CB Insights
Explore {Reata Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Reata Pharmaceuticals, Inc. To Report First Quarter 2021 Financials …
Apr 28, 2021 · Reata is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular …See details»
Reata Pharmaceuticals Reacquires Rights From AbbVie to
Oct 10, 2019 · As a result, Reata now possesses exclusive, worldwide rights to develop, manufacture and commercialize bardoxolone methyl (bardoxolone), omaveloxolone, and all …See details»
Reata Pharmaceuticals, Inc. Announces RTA 402 Entering
Apr 7, 2006 · Reata Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing novel treatments for cancer, inflammation, and neurodegenerative diseases. …See details»